{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:11:57Z","timestamp":1791555117482,"version":"4.3.4"},"reference-count":83,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jtha.2024.05.018","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T16:36:33Z","timestamp":1716827793000},"page":"2381-2392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Thromboembolic and bleeding risk in cardiac amyloidosis"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0899-9870","authenticated-orcid":false,"given":"Marco","family":"Tana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Tana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Mantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Gallina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Porreca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.05.018_bib1","first-page":"605","article-title":"Imaging findings of right cardiac amyloidosis: impact on prognosis and clinical course","volume":"26","author":"Tana","year":"2023","journal-title":"J\u00a0Ultrasound"},{"key":"10.1016\/j.jtha.2024.05.018_bib2","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.05.018_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.31083\/j.rcm2410291","article-title":"Clinical and cardiovascular magnetic resonance imaging features of cardiac amyloidosis","volume":"24","author":"Tana","year":"2023","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.jtha.2024.05.018_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.31083\/j.rcm2502073","article-title":"Current perspectives on atrial amyloidosis: a narrative review","volume":"25","author":"Tana","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.jtha.2024.05.018_bib5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-pathol-052016-100200","article-title":"Amyloidosis: insights from proteomics","volume":"12","author":"Dogan","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jtha.2024.05.018_bib6","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/ejhf.2532","article-title":"Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies","volume":"24","author":"Aimo","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jtha.2024.05.018_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ehf2.13701","article-title":"Thromboembolism and bleeding in systemic amyloidosis: a review","volume":"9","author":"Nicol","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jtha.2024.05.018_bib8","first-page":"6640","article-title":"Thromboembolic and bleeding events in transthyretin amyloidosis and coagulation system abnormalities: a review","volume":"12","author":"Napolitano","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2024.05.018_bib9","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.107.697763","article-title":"Intracardiac thrombosis and embolism in patients with cardiac amyloidosis","volume":"116","author":"Feng","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.05.018_bib10","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1161\/CIRCULATIONAHA.108.785014","article-title":"Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis","volume":"119","author":"Feng","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.05.018_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.878292","article-title":"Cerebral ischemic events: an overlooked complication of transthyretin cardiac amyloidosis in Afro-Caribbean patients","volume":"13","author":"Banydeen","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.jtha.2024.05.018_bib12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2018.10.079","article-title":"Direct current cardioversion of atrial arrhythmias in adults with cardiac amyloidosis","volume":"73","author":"El-Am","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2024.05.018_bib13","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacc.2019.01.035","article-title":"High prevalence of intracardiac thrombi in cardiac amyloidosis","volume":"73","author":"Martinez-Naharro","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2024.05.018_bib14","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/ejhf.2566","article-title":"Systemic embolism in amyloid transthyretin cardiomyopathy","volume":"24","author":"Vilches","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jtha.2024.05.018_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/13506129.2020.1798922","article-title":"Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation","volume":"28","author":"Cappelli","year":"2021","journal-title":"Amyloid"},{"key":"10.1016\/j.jtha.2024.05.018_bib16","first-page":"1128","article-title":"Left atrial structure and function in cardiac amyloidosis","volume":"18","author":"Nochioka","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jtha.2024.05.018_bib17","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.hrthm.2024.01.056","article-title":"Atrial electrofunctional predictors of incident atrial fibrillation in cardiac amyloidosis","volume":"21","author":"Sinigiani","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jtha.2024.05.018_bib18","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/ejhf.2650","article-title":"Atrial amyloidosis: mechanisms and clinical manifestations","volume":"24","author":"Vergaro","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jtha.2024.05.018_bib19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/ncn3.12601","article-title":"Amyloid neuropathy and autonomic dysfunction","volume":"10","author":"Ikeda","year":"2022","journal-title":"Neurol Clin Neurosci"},{"key":"10.1016\/j.jtha.2024.05.018_bib20","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.33963\/KP.15055","article-title":"Orthostatic hypotension and cardiovascular risk","volume":"77","author":"Fedorowski","year":"2019","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.jtha.2024.05.018_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.010573","article-title":"Orthostatic hypotension: management of a complex, but common, medical problem","volume":"15","author":"Fedorowski","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jtha.2024.05.018_bib22","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/eurheartj\/ehv093","article-title":"Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies","volume":"36","author":"Ricci","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.05.018_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/joim.12043","article-title":"Novel cardiovascular biomarkers in unexplained syncopal attacks: the SYSTEMA cohort","volume":"273","author":"Fedorowski","year":"2013","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jtha.2024.05.018_bib24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0195-668X(02)00630-9","article-title":"The role of the endothelin system in myocardial infarction--new therapeutic targets?","volume":"24","author":"Berger","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.05.018_bib25","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/HYPERTENSIONAHA.110.162768","article-title":"Orthostatic hypotension and cardiovascular risk","volume":"56","author":"Shibao","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jtha.2024.05.018_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/HJH.0b013e328365cd59","article-title":"Systolic and diastolic component of orthostatic hypotension and cardiovascular events in hypertensive patients: the Captopril Prevention Project","volume":"32","author":"Fedorowski","year":"2014","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jtha.2024.05.018_bib27","doi-asserted-by":"crossref","first-page":"14192","DOI":"10.1074\/jbc.RA118.003990","article-title":"Plasminogen activation triggers transthyretin amyloidogenesis in\u00a0vitro","volume":"293","author":"Mangione","year":"2018","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.05.018_bib28","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1538-7836.2007.02457.x","article-title":"Increased plasmin-alpha2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses","volume":"5","author":"Bouma","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.018_bib29","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3390\/cells10071768","article-title":"Transthyretin: from structural stability to osteoarticular and cardiovascular diseases","volume":"10","author":"Wieczorek","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jtha.2024.05.018_bib30","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1161\/STROKEAHA.120.033107","article-title":"Cerebral amyloid angiopathy and the fibrinolytic system: is plasmin a therapeutic target?","volume":"52","author":"Mutimer","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2024.05.018_bib31","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1182\/blood-2016-03-705228","article-title":"Biochemical and structural analysis of the interaction between \u03b2-amyloid and fibrinogen","volume":"128","author":"Zamolodchikov","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.018_bib32","first-page":"386","article-title":"Abundant proteins in platelet-rich fibrin and their potential contribution to wound healing: an explorative proteomics study and review of the literature","volume":"13","author":"Yaprak","year":"2018","journal-title":"J\u00a0Dent Sci"},{"key":"10.1016\/j.jtha.2024.05.018_bib33","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/jth.14220","article-title":"Discovery of novel plasma biomarkers for future incident venous thromboembolism by untargeted synchronous precursor selection mass spectrometry proteomics","volume":"16","author":"Jensen","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.018_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/13506129.2012.691918","article-title":"Coagulation and fibrinolysis abnormalities in familial amyloid polyneuropathy","volume":"19","author":"Takahashi","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.jtha.2024.05.018_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/13506120902879269","article-title":"Excessive fibrinolysis in AL-amyloidosis is induced by urokinae-type plasminogen activator from bone marrow plasma cells","volume":"16","author":"Uchiba","year":"2009","journal-title":"Amyloid"},{"key":"10.1016\/j.jtha.2024.05.018_bib36","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.clml.2018.03.005","article-title":"Serum free light chain difference and \u03b22 microglobulin levels are risk factors for thromboembolic events in patients with AL amyloidosis","volume":"18","author":"Park","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jtha.2024.05.018_bib37","series-title":"Reference module in biomedical sciences. Risk factors and pathophysiology of venous thromboembolism in patient with malignancy. ISBN 9780128012383","author":"Tana","year":"2023"},{"key":"10.1016\/j.jtha.2024.05.018_bib38","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1056\/NEJM200106213442516","article-title":"Deep venous thrombosis and thalidomide therapy for multiple myeloma","volume":"344","author":"Osman","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.05.018_bib39","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1182\/blood-2011-03-344333","article-title":"Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide","volume":"119","author":"Larocca","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.018_bib40","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/03009740510015203","article-title":"AL cardiac amyloidosis and arterial thromboembolic events","volume":"34","author":"Hausfater","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jtha.2024.05.018_bib41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/13506129.2020.1810010","article-title":"Anticoagulation with warfarin compared to novel oral anticoagulants for atrial fibrillation in adults with transthyretin cardiac amyloidosis: comparison of thromboembolic events and major bleeding","volume":"28","author":"Mitrani","year":"2021","journal-title":"Amyloid"},{"key":"10.1016\/j.jtha.2024.05.018_bib42","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/CIRCULATIONAHA.120.052136","article-title":"Prevalence of atrial fibrillation and thromboembolic risk in wild-type transthyretin amyloid cardiomyopathy","volume":"143","author":"Bukhari","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.05.018_bib43","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jacc.2020.10.057","article-title":"Persistence of left atrial appendage thrombus in patients with cardiac amyloidosis","volume":"77","author":"El-Am","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2024.05.018_bib44","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/hrt.74.5.541","article-title":"Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation","volume":"74","author":"Dubrey","year":"1995","journal-title":"Br Heart J"},{"key":"10.1016\/j.jtha.2024.05.018_bib45","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/01.wnl.0000276951.39112.2b","article-title":"Primary systemic amyloidosis with ischemic stroke as a presenting complication","volume":"69","author":"Zubkov","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jtha.2024.05.018_bib46","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jacep.2020.04.019","article-title":"Atrial fibrillation in transthyretin cardiac amyloidosis: predictors, prevalence, and efficacy of rhythm control strategies","volume":"6","author":"Donnellan","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jtha.2024.05.018_bib47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/13506120500537285","article-title":"Natural history of thromboembolism in AL amyloidosis","volume":"13","author":"Halligan","year":"2006","journal-title":"Amyloid"},{"key":"10.1016\/j.jtha.2024.05.018_bib48","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3324\/haematol.2015.133900","article-title":"Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis","volume":"101","author":"Bever","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.05.018_bib49","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.05.018_bib50","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.05.018_bib51","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.cjca.2019.12.034","article-title":"Canadian Cardiovascular Society\/Canadian Heart Failure Society Joint Position Statement on the evaluation and management of patients with cardiac amyloidosis","volume":"36","author":"Fine","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jtha.2024.05.018_bib52","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/sj.leu.2405062","article-title":"Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma","volume":"22","author":"Palumbo","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.jtha.2024.05.018_bib53","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.0954-6820.1967.tb07991.x","article-title":"Heparin-resistance in amyloidosis","volume":"181","author":"Christiansen","year":"1967","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jtha.2024.05.018_bib54","doi-asserted-by":"crossref","first-page":"0589","DOI":"10.1098\/rsif.2015.0589","article-title":"Heparan sulfate and heparin interactions with proteins","volume":"12","author":"Meneghetti","year":"2015","journal-title":"J\u00a0R Soc Interface"},{"key":"10.1016\/j.jtha.2024.05.018_bib55","series-title":"International review of cell and molecular biology, 325","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/bs.ircmb.2016.02.009","article-title":"Chapter six - heparan sulfate: biosynthesis, structure, and function","author":"Li","year":"2016"},{"key":"10.1016\/j.jtha.2024.05.018_bib56","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2559.1994.tb00551.x","article-title":"AA glomerular amyloid. An ultrastructural immunogold study of the colocalization of heparan sulphate proteoglycan and P component with amyloid fibrils together with changes in distribution of type IV collagen and fibronectin","volume":"24","author":"Moss","year":"1994","journal-title":"Histopathology"},{"key":"10.1016\/j.jtha.2024.05.018_bib57","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1177\/39.10.1940305","article-title":"A\u00a0temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis","volume":"39","author":"Snow","year":"1991","journal-title":"J\u00a0Histochem Cytochem"},{"key":"10.1016\/j.jtha.2024.05.018_bib58","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-3083.1991.tb01584.x","article-title":"Macromolecular properties of glycosaminoglycans in primary AL amyloid fibril extracts of lymphoid tissue origin","volume":"34","author":"Stenstad","year":"1991","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jtha.2024.05.018_bib59","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12871-023-02147-4","article-title":"Heparin-resistance in AL amyloidosis: a case report","volume":"23","author":"Van Ede","year":"2023","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.jtha.2024.05.018_bib60","doi-asserted-by":"crossref","first-page":"36","DOI":"10.36628\/ijhf.2023.0031","article-title":"Direct oral anticoagulants in patients with cardiac amyloidosis: a systematic review and meta-analysis","volume":"6","author":"Lacy","year":"2023","journal-title":"Int J Heart Fail"},{"key":"10.1016\/j.jtha.2024.05.018_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.742428","article-title":"New oral anticoagulants vs. vitamin K antagonists among patients with cardiac amyloidosis: prognostic impact","volume":"8","author":"Cariou","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jtha.2024.05.018_bib62","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/jama.2023.27188","article-title":"Apixaban to prevent recurrence after cryptogenic stroke in patients with atrial cardiopathy: the ARCADIA randomized clinical trial","volume":"331","author":"Kamel","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2024.05.018_bib63","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2141.2000.02183.x","article-title":"Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis","volume":"110","author":"Mumford","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.05.018_bib64","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/jama.1983.03330340064034","article-title":"Bleeding manifestations in 100 patients with amyloidosis","volume":"249","author":"Yood","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2024.05.018_bib65","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1016\/j.cgh.2019.09.046","article-title":"A\u00a0case of amyloid light-chain amyloidosis presenting with submucosal hematoma and bleeding in the upper gastrointestinal tract","volume":"18","author":"Tanaka","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jtha.2024.05.018_bib66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14309\/crj.0000000000000066","article-title":"Gastric amyloidosis causing nonvariceal upper gastrointestinal bleeding","volume":"6","author":"Sundaram","year":"2019","journal-title":"ACG Case Rep J"},{"key":"10.1016\/j.jtha.2024.05.018_bib67","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bmt.1703155","article-title":"High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis","volume":"28","author":"Kumar","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtha.2024.05.018_bib68","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s11894-013-0350-4","article-title":"Small bowel amyloidosis","volume":"15","author":"Gould","year":"2013","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jtha.2024.05.018_bib69","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3324\/haematol.2012.068155","article-title":"Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience","volume":"98","author":"Cowan","year":"2013","journal-title":"Haematologica"},{"issue":"Suppl 2","key":"10.1016\/j.jtha.2024.05.018_bib70","article-title":"Bleeding events in patients with cardiac amyloidosis","volume":"41","author":"Schrutka","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.05.018_bib71","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5892707","article-title":"Senile systemic amyloidosis presenting as hematuria: a rare presentation and review of literature","volume":"2020","author":"Jayakrishnan","year":"2020","journal-title":"Case Rep Med"},{"key":"10.1016\/j.jtha.2024.05.018_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100256","article-title":"Amyloidosis and risk of stroke after transcatheter aortic valve replacement: it takes two to tango?","volume":"2","author":"Ricci","year":"2023","journal-title":"JACC Adv"},{"key":"10.1016\/j.jtha.2024.05.018_bib73","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oead106","article-title":"Cardiac amyloidosis and aortic stenosis: a state-of-the-art review","volume":"3","author":"Jaiswal","year":"2023","journal-title":"Eur Heart J Open"},{"key":"10.1016\/j.jtha.2024.05.018_bib74","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10741-023-10350-1","article-title":"Valvular heart disease in patients with cardiac amyloidosis","volume":"29","author":"Aimo","year":"2024","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jtha.2024.05.018_bib75","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.05.018_bib76","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.011433","article-title":"Aortic valve calcium in patients with transthyretin cardiac amyloidosis: a propensity-matched analysis","volume":"13","author":"Hussain","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jtha.2024.05.018_bib77","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.jaccas.2020.10.002","article-title":"Subthreshold aortic valve calcium scores in severe aortic stenosis and transthyretin cardiac amyloidosis","volume":"2","author":"Hussain","year":"2020","journal-title":"JACC Case Rep"},{"key":"10.1016\/j.jtha.2024.05.018_bib78","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.jaccas.2020.10.011","article-title":"Aortic stenosis and cardiac amyloidosis: watch out for traps!","volume":"2","author":"Ternacle","year":"2020","journal-title":"JACC Case Rep"},{"key":"10.1016\/j.jtha.2024.05.018_bib79","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jaccao.2021.06.006","article-title":"ATTR amyloidosis: current and emerging management strategies: JACC: CardioOncology state-of-the-art review","volume":"3","author":"Griffin","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jtha.2024.05.018_bib80","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.amjcard.2016.07.011","article-title":"Meta-analysis of perioperative stroke and mortality in transcatheter aortic valve implantation","volume":"118","author":"Muralidharan","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jtha.2024.05.018_bib81","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jacep.2019.10.013","article-title":"No association between CHADS-VASc score and left atrial appendage thrombus in patients with transthyretin amyloidosis","volume":"5","author":"Donnellan","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jtha.2024.05.018_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101188","article-title":"Effectiveness and safety of oral anticoagulants in cardiac amyloidosis: lights and shadows","volume":"48","author":"Di Lisi","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.jtha.2024.05.018_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100255","article-title":"Outcomes of transcatheter aortic valve replacement in patients with coexisiting amyloidosis: mortality, stroke, and readmission","volume":"2","author":"Elzeneini","year":"2023","journal-title":"JACC Adv"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624003040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624003040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T01:53:34Z","timestamp":1724378014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624003040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":83,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1538783624003040"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.05.018","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thromboembolic and bleeding risk in cardiac amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}